Skip to main content
Jenessa Smith

Jenessa Smith

Director Process Development, ArsenalBio

Jenessa Smith earned her PhD at the University of Pennsylvania under Daniel J. Powell Jr., developing novel chimeric antigen receptor (CAR) and T-cell receptor (TCR) therapies to fight cancer. Jenessa was also on the team that initiated the first canine CAR T veterinary clinical trial in pet dogs with B cell lymphoma. Jenessa is currently the Director of Process Development at Arsenal Biosciences, leading a team to develop novel, non-virally edited integrated T cell therapies (ICT) for solid tumors including ovarian and renal cell cancers. Jenessa is passionate about cancer research and advancing cellular therapies for patients.